Showing results (31-40 of 9,894) with videos related to
Sort By:
Pageof 990
Bone Marrow Transplantation|November 7, 2002
Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignanciesR Chatterjee, P D KottaridisBone Marrow Transplantation|November 7, 2002
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registryL Fouillard, M Labopin, A Gratwohl, et al.Bone Marrow Transplantation|November 7, 2002
Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experienceN Basara, E Roemer, L Kraut, et al.Bone Marrow Transplantation|September 1, 1999
A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysisM Gandhi, H Jestice, M Scott, et al.Bone Marrow Transplantation|September 1, 1999
A case of hemophagocytic lymphohistiocytosis with prolonged remission after syngeneic bone marrow transplantationD Hasegawa, K Sano, Y Kosaka, et al.Bone Marrow Transplantation|April 28, 1999
An uncommon case of late thrombotic thrombocytopenic purpura (42 months) after autologous peripheral blood stem cell (PBSC) transplantation in a childM González-Vicent, M A Díaz, L MaderoBone Marrow Transplantation|April 28, 1999
Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemiaR Martino, A Shah, P Romero, et al.Bone Marrow Transplantation|April 27, 1999
Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)G A Martín-Henao, M Picón, A Limón, et al.Bone Marrow Transplantation|April 27, 1999
Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancerF de Arriba, J Corral, F Ayala, et al.Bone Marrow Transplantation|April 27, 1999
Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantationN Milpied, M Coste-Burel, F Accard, et al.Pageof 990